CA Gallbladder and Cholangiocarcinoma patients, Non malignancy patients (e.g. CBD stone) CA gallbladder, Cholangiocarcinoma, Amylase, Biliary amylase, ERCP
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. A minimum age of 20 years old 2. Undergoing Endoscopic retrograde cholangiopancreatography (ERCP) at Thammasat University hospital
Exclusion criteria
Exclusion criteria: 1. Pregnant patients 2. Unstable vital signs 3. Contraindicated for Endoscopic retrograde cholangiopancreatography (ERCP) 4. Allergy to contrast media used in Endoscopic retrograde cholangiopancreatography (ERCP) 5. Previous ERCP with sphincterotomy 6. CA head of pancreas, Ampullary cancer, and CA 2nd part of duodenum
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The correlation between biliary amylase which represent pancreatobiliary reflux and incidence of biliary tract cancer (gallbladder cancer and bile duct cancer) At intervention Laboratory value of Biliary amylase | — |
Secondary
| Measure | Time frame |
|---|---|
| Correlation of biliary tract cancer and choledocholithiasis At intervention Presentation of CBD stone and Cholangiocarcinoma/ CA Gallbladder,Correlation of biliary tract cancer and smoking/alcohol drinking At intervention History of smoking and Alcohol drinking in patients diagnosed with Cholangiocarcinoma/ CA Gallbladder | — |
Countries
Thailand
Contacts
Thammasat University